These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 608527)

  • 1. A vaccine and immune serum for ascites tumor of mice and therapy of skin tumors.
    Ryu E
    Dev Biol Stand; 1977 Apr 13-15; 38():381-5. PubMed ID: 608527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody.
    Saha S; Mondal S
    J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
    Saha S; Mondal S
    Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of the growth of Ehrlich transplantable carcinoma in mice by antichorionic immune serum].
    Dil'man VM; Tsyrlina EV; Bulovskaia LN; Bobrov IuF
    Vopr Onkol; 1983; 29(2):62-4. PubMed ID: 6836972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice.
    Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P
    Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of antitumor vaccine on the recurrence of solid tumors in mice subjected to surgery].
    Zatula DG; Bikhunov VL; Zagoruĭko EE
    Eksp Onkol; 1984; 6(1):47-9. PubMed ID: 6499731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ascites tumour with cytolytic serum obtained by double immunization.
    Mihaescu GH; Micu N; Popp I; Comisel V; Mihaescu I
    Neoplasma; 1974; 21(3):297-302. PubMed ID: 4424781
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors.
    Matsumoto K; Leggatt GR; Zhong J; Liu X; de Kluyver RL; Peters T; Fernando GJ; Liem A; Lambert PF; Frazer IH
    J Natl Cancer Inst; 2004 Nov; 96(21):1611-9. PubMed ID: 15523090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of Ehrlich ascites carcinoma (EAC) with antiserum to modified EAC.
    Das AK; Roy DK
    Indian J Exp Biol; 1985 Nov; 23(11):641-3. PubMed ID: 3833682
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
    Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent leukocytes.
    Dobaczewska H
    Neoplasma; 1982; 29(3):323-5. PubMed ID: 7133227
    [No Abstract]   [Full Text] [Related]  

  • 13. [Migration capacity of tumor cells treated with immune sera].
    Lebedev KA; Kaulen DR; Khorobrykh VV; D'iakov GN; Simonova AV
    Biull Eksp Biol Med; 1977 Dec; 84(12):712-4. PubMed ID: 597608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the effects of host suppression on the adoptive immunotherapy of subcutaneous and visceral tumors.
    Chang AE; Shu SY; Chou T; Lafreniere R; Rosenberg SA
    Cancer Res; 1986 Jul; 46(7):3426-30. PubMed ID: 2939946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent splenocytes.
    Dobaczewska H
    Neoplasma; 1984; 31(2):165-8. PubMed ID: 6717686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vivo studies on multiple-step cancer therapy using immune antibodies for attack induction. Variant for metastasis treatment].
    von Ardenne M; Chaplain RA; Prokop O
    Dtsch Gesundheitsw; 1969 Aug; 24(34):1589-93. PubMed ID: 5376219
    [No Abstract]   [Full Text] [Related]  

  • 17. The antitumor action of bacterial extracts. II. Suppressive effects of extracts of E. coil on subcutaneous tumors of mouse.
    Watanabe T; Sakamoto I
    Jpn J Exp Med; 1982 Feb; 52(1):39-44. PubMed ID: 6752491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of mouse interferons on the development of Ehrlich ascitic carcinoma].
    Solov'ev VD; Krispin TI; Balandin IG
    Biull Eksp Biol Med; 1980 Mar; 89(3):330-2. PubMed ID: 6155950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules.
    Nemeckova S; Smahel M; Hainz P; Mackova J; Zurkova K; Gabriel P; Indrova M; Kutinova L
    Neoplasma; 2007; 54(4):326-33. PubMed ID: 17822323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.